Marina Urman-Yotam, MD
Psychiatry · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 18 years
- University of California, Davis School of Medicine, 2008
Offices
2 locations · County of San Mateo · 316 clinicians in this group
Hospitals listed: San Mateo Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Urman-Yotam’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A109603 · Current
Licensed to practise in California · since 2009 · expires 2027-01-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Medicaid work
$18,801 in 2024
Medicaid paid $18,801 for 361 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 149 | $9,427 |
| Short return visit (20+ min) | 212 | $9,373 |
| 2024 | 361 | 2 | 34 | $18,801 |
| 2023 | 266 | 2 | 27 | $8,658 |
| 2022 | 189 | 1 | 23 | $2,549 |
| 2021 | 209 | 1 | 27 | $573 |
| 2020 | 110 | 2 | 20 | $2,739 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 225 | $7,048 |
| Return visit (30+ min) | 41 | $1,610 |
2022
| Short return visit (20+ min) | 189 | $2,549 |
2021
| Short return visit (20+ min) | 209 | $573 |
2020
| Return visit (30+ min) | 96 | $2,739 |
| Short return visit (20+ min) | 14 | $0 |
Drugs they prescribed that Part D paid
$28,857
Pharmacies billed $28,857 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 644) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
639 generic and fewer than 11 brand-name prescriptions · $28,857 in drug cost · 18 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lurasidone | 13 | $3,790 | $292 |
| Venlafaxine Hcl Er | 13 | $2,162 | $166 |
| Quetiapine | 17 | $1,253 | $74 |
| Mirtazapine | 74 | $1,125 | $15 |
| Trazodone | 66 | $776 | $12 |
See all 21 drugs
| Lurasidone | 13 | $3,790 | $292 |
| Venlafaxine Hcl Er | 13 | $2,162 | $166 |
| Quetiapine | 17 | $1,253 | $74 |
| Mirtazapine | 74 | $1,125 | $15 |
| Trazodone | 66 | $776 | $12 |
| Sertraline | 82 | $647 | $8 |
| Lamotrigine | 25 | $488 | $20 |
| Duloxetine | 42 | $458 | $11 |
| Buspirone | 12 | $306 | $25 |
| Escitalopram | 16 | $284 | $18 |
| Gabapentin | 12 | $241 | $20 |
| Clonazepam | 78 | $183 | $2 |
| Aripiprazole | 12 | $170 | $14 |
| Hydroxyzine | 33 | $142 | $4 |
| Bupropion Xl | 23 | $141 | $6 |
| Bupropion Hcl Sr | 13 | $140 | $11 |
| Bupropion | 13 | $133 | $10 |
| Diazepam | 13 | $107 | $8 |
| Olanzapine | 13 | $65 | $5 |
| Fluoxetine | 22 | $43 | $2 |
| Zolpidem | 12 | $15 | $1 |
Year by year
| 2024 | 644 | 41 | 0% (0) | None | $28,857 |
| 2023 | 592 | 37 | 0% (0) | None | $26,763 |
| 2022 | 606 | 44 | 0% (0) | None | $21,584 |
| 2021 | 712 | 42 | 0% (0) | None | $11,808 |
| 2020 | 750 | 45 | 0% (0) | None | $13,750 |
| 2019 | 67 | 14 | 0% (0) | None | $1,478 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Mirtazapine | 65 | $1,434 | $22 |
| Trazodone | 76 | $1,024 | $13 |
| Duloxetine | 39 | $713 | $18 |
| Quetiapine | 14 | $638 | $46 |
| Sertraline | 62 | $626 | $10 |
| Escitalopram | 31 | $509 | $16 |
| Clonazepam | 40 | $440 | $11 |
| Bupropion Hcl Sr | 13 | $336 | $26 |
| Bupropion Xl | 33 | $270 | $8 |
| Bupropion | 12 | $231 | $19 |
| Lamotrigine | 12 | $210 | $18 |
| Gabapentin | 12 | $158 | $13 |
| Diazepam | 11 | $88 | $8 |
| Hydroxyzine | 24 | $73 | $3 |
| Olanzapine | 29 | $66 | $2 |
| Fluoxetine | 17 | $63 | $4 |
| Zolpidem | 17 | $22 | $1 |
| Citalopram Hbr | 11 | $14 | $1 |
2022: 18 drugs
| Aripiprazole | 30 | $6,320 | $211 |
| Mirtazapine | 60 | $1,560 | $26 |
| Quetiapine | 18 | $752 | $42 |
| Duloxetine | 35 | $691 | $20 |
| Trazodone | 71 | $630 | $9 |
| Escitalopram | 33 | $568 | $17 |
| Sertraline | 54 | $505 | $9 |
| Lamotrigine | 17 | $459 | $27 |
| Clonazepam | 23 | $409 | $18 |
| Bupropion Hcl Sr | 18 | $182 | $10 |
| Bupropion Xl | 25 | $177 | $7 |
| Diazepam | 12 | $94 | $8 |
| Olanzapine | 14 | $76 | $5 |
| Venlafaxine Hcl Er | 14 | $75 | $5 |
| Fluoxetine | 25 | $54 | $2 |
| Lorazepam | 36 | $47 | $1 |
| Zolpidem | 33 | $32 | $1 |
| Citalopram Hbr | 13 | $16 | $1 |
2021: 20 drugs
| Mirtazapine | 74 | $1,825 | $25 |
| Quetiapine | 21 | $1,040 | $50 |
| Trazodone | 84 | $787 | $9 |
| Sertraline | 64 | $715 | $11 |
| Duloxetine | 77 | $492 | $6 |
| Clonazepam | 12 | $395 | $33 |
| Bupropion Xl | 24 | $385 | $16 |
| Escitalopram | 28 | $368 | $13 |
| Aripiprazole | 31 | $314 | $10 |
| Fluoxetine | 29 | $233 | $8 |
| Lamotrigine | 24 | $220 | $9 |
| Olanzapine | 22 | $175 | $8 |
| Venlafaxine Hcl Er | 19 | $175 | $9 |
| Diazepam | 20 | $97 | $5 |
| Buspirone | 23 | $89 | $4 |
| Bupropion Hcl Sr | 12 | $87 | $7 |
| Paroxetine | 11 | $79 | $7 |
| Lorazepam | 48 | $71 | $1 |
| Zolpidem | 36 | $33 | $1 |
| Citalopram Hbr | 19 | $26 | $1 |
2020: 21 drugs
| Mirtazapine | 58 | $1,999 | $34 |
| Aripiprazole | 35 | $1,696 | $48 |
| Quetiapine | 40 | $1,446 | $36 |
| Bupropion Xl | 41 | $874 | $21 |
| Buspirone | 33 | $809 | $25 |
| Sertraline | 53 | $701 | $13 |
| Trazodone | 93 | $640 | $7 |
| Duloxetine | 57 | $546 | $10 |
| Amitriptyline | 18 | $428 | $24 |
| Escitalopram | 19 | $287 | $15 |
| Lamotrigine | 21 | $185 | $9 |
| Bupropion Hcl Sr | 17 | $133 | $8 |
| Dextroamphetamine-Amphetamine | 11 | $126 | $11 |
| Olanzapine | 21 | $120 | $6 |
| Lorazepam | 38 | $98 | $3 |
| Diazepam | 19 | $96 | $5 |
| Fluoxetine | 26 | $93 | $4 |
| Lithium Carbonate | 11 | $83 | $8 |
| Venlafaxine Hcl Er | 12 | $64 | $5 |
| Citalopram Hbr | 24 | $36 | $2 |
| Zolpidem | 23 | $30 | $1 |
Money from drug and device companies
$265 in 2024
| 2024 | 2 | 2 | None | $265 |
| 2019 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega | $143 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $122 | 1 payment
|
See all 2 published payments
| Janssen Pharmaceuticals | Meals · 2024-03-20 | Invega | $143 |
| Neurocrine Biosciences | Meals · 2024-02-15 | Ingrezza | $122 |
See earlier years (2019)
2019: $17
| Indivior | Sublocade | $17 | 1 payment
|
Professional record
- NPI
- 1114187960
- Licence
- CA A109603California A109603: Current · expires 2027-01-31
- Trained
- University of California, Davis School of Medicine, 2008 · 18 years ago
- Group
- County of San Mateo
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 222 W 39th Ave, San Mateo, CA, 94403
- NPI first listed
- 2008-06-16
- NPI last updated
- 2019-05-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Quarry Road, Stanford, CA, 94305